ETHICS IN EASTHETIC MEDECINE CAN BECOME A COMMITMENT FOR ALL

AestETHICS is the global conversation between aesthetic medicine specialists and patients.
AestETHICS was born from the voices of individual physicians who share their vision for the ethical use of aesthetic medicine.

IBSA Derma has always been a promoter of culture on aesthetic medicine and has intercepted and amplified the voices of this group of physicians, fostering a reflection on clinical practice with a communication and in-depth project that aims to initiate a broader and deeper conversation on an international level, for the benefit of patients as well.
The project aims to create a system of education and information, with the support of scientific societies as well, that can have a positive impact on the entire field of aesthetic medicine while enhancing the uniqueness and authentic beauty of each individual.
IBSA Derma and its support have promoted and fostered a connection and discussion between experts, professionals in the field, scientific societies and training schools, with the aim of collecting data on the vision of ethics in aesthetic medicine.

The first concrete result of this discussion is a Position Paper entitled “The Aesthetic Medicine: International Dialogue on the Relationship between Medicine, Beauty And Ethics” presented in Paris, at the IMCAS 2023 Congress.

The Position Paper then led to the publication of a scientific article in the Philosophy, Ethics, and Humanities in Medicine Journal entitled “The ethical foundations of patient-centered care in aesthetic medicine.”

IBSA Derma’s commitment to AestETHICS continues, and throughout 2024 it aims to support the sector’s training schools by organizing lectures on ethics in aesthetic medicine to be included in the residency training of future generations of aesthetic medicine physicians.

SUPPORTED BY

ARE YOU A HEALTHCARE PROFESSIONAL?

Take part in the dialogue by registering on the form below, you will get access to the Consensus Paper and lots of exclusive content such as videos, social posts and personalized certificate.

Self-certification of medical qualification

Privacy *

Click here to read the privacy notice

Information notice pursuant to art.13 of Regulation EU 2016/679 of the European Parliament and of the Council of 27 April 2016 (General Data Protection Regulation, so-called “GDPR”)

Information notice for aestETHICS Campaign

In accordance with the current personal data protection regulations, IBSA Farmaceutici Italia Srl (hereinafter, the “IBSA” or “Company”) as “Data Controller”, is required to provide certain information regarding the use of your personal data.

 

  1. Purpose of the personal data processing

The treatment of your personal data is necessary for the following purpose:

a) To participate in the aestETHICS Campaign

b) “Marketing communication”: information relating to IBSA products and services and related activities (training, seminaries, etc.), institutional communication on IBSA activities (congresses, launch of new products, marketing communication) through dedicated IBSA personnel and/or forwarding of promotional material through printed or digital channels (i.e. email).

 

  1. Nature of the provision of the personal data and consent

We inform you that the processing of your personal data for the purpose referred to in point 1a of this information is carried out in accordance with art. 6.1 lett. b) of the EU Regulation 2016/679, so the provision of data is optional but necessary for the performance of the contractual relationship between the parties. Any refusal will make it impossible for you to participate to the project aestETHICS Campaign.

We inform you that the processing of your personal data for the purpose referred to in point 1b of this information is carried out pursuant to art. 6.1 lett. a) of the EU Regulation 2016/679, so the consent is optional but essential for the achievement of the purpose itself. Any refusal to provide consent will not allow the achievement of the purpose itself.

 

  1. How the data are processed

The data are processed through computer procedures or by automated means or paper by persons, internal or external, specifically assigned to this task and required to confidentiality with logic closely related to the purposes for which the data were collected in any case suitable to ensure the security and confidentiality of the data are protected by security measures provided by law, to prevent unauthorized access, loss or destruction.

 

  1. How long the data are kept

The data will be kept for the time strictly necessary for the accomplishment of the purposes set out in this notice and in any event up to the statutory and legal time limit in compliance with the rights and the resulting obligations. In particular the retention time for your personal data mentioned in point 1a and point 1b is 2 years, in addition to a further year to carry out the activities for the cancellation and / or deletion of data.

 

  1. Scope of circulation of the data

The data may be used by personnel of the Company and of the company IBSA Institut Biochimique SA and any of its affiliates, that have been given appropriate operating instructions under an obligation of confidentiality. The data may also be used by third-party providing operational and additional services on behalf of the Company, which act as external data processors under the direction and supervision of the Company.

The list of the Data Processors is available by sending a request to privacy@ibsa.ch.

 

  1. Communication of the data

In accordance with the laws and regulations that we are subject to, we may be required to communicate the data to the competent Authorities and healthcare associations in third countries outside the EU and to legitimate recipients in accordance with the law and the regulations. These parties will act as independent Data Controllers.

 

  1. Transfer of the data abroad

The aforementioned personal data may be transferred to the company Institut Biochimique SA in Switzerland, solely for the purposes set out in paragraph 1. In accordance with the laws and regulations to which we are subject to, your personal data may also be communicated and/or transferred to organizations located in other countries, both in EU countries and outside the EU, including countries that may not provide the same level of protection as provided by the applicable legislation, we inform you that the transfer of data abroad is subject to specific guarantees for the protection of personal data through the adoption of standard contractual clauses.

 

  1. Rights of the data subject

In relation to the processing of your personal data, you have the right to be informed at any time about your data held by the Company and how they are used. You also have the right to have the data updated, corrected or erased, to request their portability or restriction of processing, in the cases provided for by law, and to object to the processing of the data unless the Company has a legitimate interest in the data. To exercise your rights and to obtain more detailed information about the persons or categories of persons to whom the data are communicated and/or transferred or who become aware of the data as controllers or processors, you can contact us:

  • by e-mail, at: privacy@ibsa.ch;
  • by post, at: IBSA Farmaceutici Italia Srl, Ufficio Privacy, via della Filanda 30 – 26900 Lodi (LO) – Italy.

Lastly, we remind you that you have the right to lodge a complaint with the Personal Data Protection Authority if you consider that your rights have not been respected or that you have not received a response to your requests in accordance with the law.

 

  1. Data Controller

The Data Controller is IBSA Farmaceutici Italia Srl with registered office in Via Martiri di Cefalonia, 2 – 26900 Lodi (LO), Italy.

 

  1. Data Protection Officer

The Company has appointed a Data Protection Officer or DPO. The DPO can be contacted via the following communication channel: dpo@ibsa.it.

* Required fields

AestETHICS

Thank you. Check your email and you will have access to the Consensus Paper.

AestETHICS ENDORSER

DR. ANDREA MARGARA

DR. ANDREA MARGARA

DR. ANTONELLO TATEO

DR. ANTONELLO TATEO

DR. EDITTA BUTTURA

DR. EDITTA BUTTURA

DR. BEATRIZ MOLINA

DR. BEATRIZ MOLINA

DR. HUGUES CARTIER

DR. HUGUES CARTIER

DR. ANDREA MARGARA

“There is a need for discussion on ethics with our colleagues and the scientific community to help us reach a consensus about our practices.
It is important to establish common rules, draw up a code of ethics and create recommendations.
Ethics is about respect, humanity and care. ‘Primum non nocere’ is the fundamental principle of medical practice.”

DR. ANTONELLO TATEO

“In recent years, the widespread popularity of aesthetic medicine treatments, the influence of social media and the emergence of new transgressive trends, have made us face new ethical challenges.
Now it’s time for the role of beauty to move towards a more mature and holistic approach.”

DR. EDITTA BUTTURA

“I firmly believe that it’s essential for companies, doctors and patients to unite under a shared vision, which is to work in complete compliance with ethical principles.”

DR. BEATRIZ MOLINA

“I think it’s important to establish some clear rules and guidelines to instil ethical values in our work and profession.
We must remember that aesthetic medicine is not just a business, but a means to help our patients fully realise their physical and emotional potential.
Ethics must be a cornerstone of our work. Ethics means respecting the standards of beauty and harmony, and, most importantly, putting patient care first.”

DR. HUGUES CARTIER

“Together with a team of doctors and the support of IBSA, we are conducting research on the ethical use of aesthetic medicine to prioritise our patients’ well-being.
It is important to remain open in a changing society without restricting people’s freedom of expression. However, we must set boundaries to protect our patients’ image.”